Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?

Brembati V, Faustini G, Longhena F, Bellucci A.

Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.

New Pieces for an Old Puzzle: Approaching Parkinson's Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics

Ortega Moreno L, Bagues A, Martínez V, Abalo R.

Nutrients. 2023 Jun 16;15(12):2775. doi: 10.3390/nu15122775.

REM behavior disorder: When Parkinson's disease meets Morpheus

Dodet P.

Rev Neurol (Paris). 2023 Oct;179(7):667-674. doi: 10.1016/j.neurol.2023.08.005. Epub 2023 Aug 17.

Involvement of antioxidant enzymes in Parkinson's disease

Tahavvori A, Gargari MK, Yazdani Y, Mamalo AS, Beilankouhi EAV, Valilo M.

Pathol Res Pract. 2023 Sep;249:154757. doi: 10.1016/j.prp.2023.154757. Epub 2023 Aug 9.

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson's disease

Miller SJ, Darji RY, Walaieh S, Lewis JA, Logan R.

Front Neurol. 2023 Sep 28;14:1271941. doi: 10.3389/fneur.2023.1271941. eCollection 2023.

The Role of Immune Dysfunction in Parkinson's Disease Development

Cossu D, Hatano T, Hattori N.

Int J Mol Sci. 2023 Nov 26;24(23):16766. doi: 10.3390/ijms242316766.

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease

Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I.

Alzheimers Res Ther. 2023 Jun 8;15(1):106. doi: 10.1186/s13195-023-01249-y.

The PPN and motor control: Preclinical studies to deep brain stimulation for Parkinson's disease

Lin C, Ridder MC, Sah P.

Front Neural Circuits. 2023 Feb 28;17:1095441. doi: 10.3389/fncir.2023.1095441. eCollection 2023.

Current Perspectives: Obesity and Neurodegeneration - Links and Risks

Kueck PJ, Morris JK, Stanford JA.

Degener Neurol Neuromuscul Dis. 2023 Dec 31;13:111-129. doi: 10.2147/DNND.S388579. eCollection 2023.

Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's disease

Alarcón TA, Presti-Silva SM, Simões APT, Ribeiro FM, Pires RGW.

Neural Regen Res. 2023 Jul;18(7):1450-1456. doi: 10.4103/1673-5374.360264.

Genetic modifiers of synucleinopathies-lessons from experimental models

Lee RMQ, Koh TW.

Oxf Open Neurosci. 2023 Mar 9;2:kvad001. doi: 10.1093/oons/kvad001. eCollection 2023.

The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease

Justich MB, Rojas OL, Fasano A.

Semin Neurol. 2023 Aug;43(4):553-561. doi: 10.1055/s-0043-1771468. Epub 2023 Aug 10.

Diabetes: a tipping point in neurodegenerative diseases

Santiago JA, Karthikeyan M, Lackey M, Villavicencio D, Potashkin JA.

Trends Mol Med. 2023 Dec;29(12):1029-1044. doi: 10.1016/j.molmed.2023.09.005. Epub 2023 Oct 10.

Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease

Xu Y, Wang S, Zhu P.

Curr Stem Cell Res Ther. 2023;18(2):154-162. doi: 10.2174/1574888X17666220426114050.

Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin

Tchekalarova J, Tzoneva R.

Int J Mol Sci. 2023 Feb 3;24(3):3022. doi: 10.3390/ijms24033022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias